Description: Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was founded in 1989 and is based in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Berhyanda Limited.
Home Page: suvenpharm.com
Galaxy Towers
Hyderabad,
500081
India
Phone:
91 40 2354 9414
Officers
| Name | Title |
|---|---|
| Dr. Sudhir Kumar Singh Ph.D. | Chief Executive Officer |
| Mr. Himanshu Agarwal | Chief Financial Officer |
| Ms. Cyndrella Carvalho | Head of Investor Relations |
| Mr. Kundan Kumar Jha | Company Secretary & Compliance Officer |
| Mr. Gaurav Narain Bahadur | Chief Human Resources Officer |
| Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju | MD & Director |
| Mr. Subba Raju Komaravolu | Chief Strategy Officer |
| Mr. Sunder Venkatraman | Vice President of Corporate Affairs |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 136.4211 |
| Price-to-Book MRQ: | 16.7504 |
| Price-to-Sales TTM: | 35.4005 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 0 |